Juan Hui Yu, Zhou Albert E, Hoegler Karl M, Khachemoune Amor
Virginia Commonwealth University School of Medicine, Richmond, VA, USA.
Department of Dermatology, University of Maryland School of Medicine, Baltimore, MD, USA.
Arch Dermatol Res. 2023 May;315(4):707-727. doi: 10.1007/s00403-022-02447-8. Epub 2022 Nov 7.
The vast majority of skin cancers can be classified into two main types: melanoma and keratinocyte carcinomas. The most common keratinocyte carcinomas include basal cell carcinoma (BCC) and squamous cell carcinoma (SCC). Multiple familial syndromes have been identified that can increase the risk of developing SCC, BCC, and/or melanoma. The major syndromes include oculocutaneous albinism for SCC, basal cell nevus syndrome for BCC, familial atypical multiple mole-melanoma syndrome, and hereditary breast and ovarian cancer syndrome for melanoma. In addition, familial syndromes that can predispose individuals to all three major skin cancers include xeroderma pigmentosum and Li-Fraumeni syndrome. This review highlights the epidemiology, risk factors, pathogenesis, and etiology of the major and minor syndromes to better identify and manage these conditions. Current investigational trials in genomic medicine are making their way in revolutionizing the clinical diagnosis of these familial syndromes for earlier preventative measures and improvement of long-term prognosis in these patients.
黑色素瘤和角质形成细胞癌。最常见的角质形成细胞癌包括基底细胞癌(BCC)和鳞状细胞癌(SCC)。已确定多种家族性综合征可增加患SCC、BCC和/或黑色素瘤的风险。主要综合征包括与SCC相关的眼皮肤白化病、与BCC相关的基底细胞痣综合征、家族性非典型多发痣-黑色素瘤综合征以及与黑色素瘤相关的遗传性乳腺癌和卵巢癌综合征。此外,可使个体易患所有三种主要皮肤癌的家族性综合征包括着色性干皮病和李-佛美尼综合征。本综述重点介绍了主要和次要综合征的流行病学、危险因素、发病机制和病因,以更好地识别和管理这些疾病。目前基因组医学的研究性试验正在彻底改变这些家族性综合征的临床诊断,以便采取更早的预防措施并改善这些患者的长期预后。